Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc. (CELZ) Revenue
Annual & quarterly revenue history · segment & region breakdown
CELZ · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCreative Medical Technology Holdings, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 45.45% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -45.45% |
| 2024-12-31 | $0.00B | +$0.00B | +22.22% |
| 2023-12-31 | $0.00B | -$0.00B | -89.84% |
| 2022-12-31 | $0.00B | +$0.00B | +0.96% |
| 2021-12-31 | $0.00B | -$0.00B | -46.65% |
| 2020-12-31 | $0.00B | -$0.00B | -0.60% |
| 2019-12-31 | $0.00B | +$0.00B | +33.04% |
| 2018-12-31 | $0.00B | +$0.00B | +2491.67% |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Creative Medical Technology Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Creative Medical Technology Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Creative Medical Technology Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CELZ revenue · 4 questionsCELZ's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 45.45% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Creative Medical Technology Holdings, Inc. SEC filings · GAAP · Creative Medical Technology Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026